Japanese Pharmacopoeia
Japanese Pharmacopoeia (JP) is the official pharmacopoeia of Japan. It is published by the Ministry of Health, Labour and Welfare of Japan. The Japanese Pharmacopoeia is a legal document which sets the standards for the identity, quality, purity, strength, and dosage of pharmaceutical substances and pharmaceutical products marketed in Japan.
History[edit]
The first edition of the Japanese Pharmacopoeia was published in 1886. Since then, it has been revised and updated periodically to incorporate advances in pharmaceutical sciences and to meet the needs of public health.
Content[edit]
The Japanese Pharmacopoeia contains monographs for pharmaceutical substances, preparations and dosage forms, and provides general tests, processes and apparatus to be used in their manufacture and quality control. It also includes biological products, radiopharmaceuticals, and herbal medicines.
Standards[edit]
The standards set in the Japanese Pharmacopoeia are legally enforceable and are intended to ensure the safety, efficacy and quality of pharmaceutical products. They are based on the latest scientific knowledge and are developed in consultation with experts in the field.
International Harmonization[edit]
The Japanese Pharmacopoeia is part of the international harmonization of pharmacopoeias, along with the United States Pharmacopeia and the European Pharmacopoeia. This harmonization aims to ensure that the same standards and procedures are used worldwide, to facilitate international trade and to protect public health.
See also[edit]
